Skip to main content
. 2021 Jul 23;8:695222. doi: 10.3389/fvets.2021.695222

Table 4.

Comparison of survival between dogs only treated with immunotherapy and dogs also undergoing surgery.

Group N Mean (D) Std error Median (D) Lower 95% Upper 95% p
AdCD40L only 12 191 95.2 80 41 160
Surgery plus AdCD40L 20 778 187.8 448* 260 1,083 <0.0001
Combined 32 558 131.6 285 130 495

Survival was significantly longer in dogs that also underwent surgery combined with immunotherapy (p < 0.0001).

*

Significant, p < 0.05.